nephropathic


Also found in: Thesaurus, Medical, Encyclopedia.

ne·phrop·a·thy

 (nə-frŏp′ə-thē)
n. pl. ne·phrop·a·thies
A disease or abnormality of the kidney.

neph′ro·path′ic (nĕf′rə-păth′ĭk) adj.

nephropathic

(ˌnɛfrəˈpæθɪk)
adj
(Medicine) characterized by or relating to nephropathy
References in periodicals archive ?
This clarifies our near-term priorities, which are to maximize the reach of PROCYSBI in nephropathic cystinosis, further the development of RP103 in Huntington's and mitochondrial diseases, prepare for QUINSAIR'S launch and initiate at least one trial in nontuberculous mycobacteria or bronchiectasis.
From its traditional use in Ayurvedic medicine as a rasayana drug, Asparagus racemosus (AR) (shatavari) is now used worldwide as a medicinal plant, with reported pharmacological activities including adaptogenic, anti-stress, gastroduodenal ulcer protective, anticancer, immunomodulatory and diabetic-induced anti nephropathic effects.
The program will provide access to Raptor Pharmaceuticals Corp's PROCYSBI[R] (cysteamine bitartrate) for individual patients with nephropathic cystinosis.
Food and Drug Administration (FDA) has approved PROCYSBI (TM)(cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older.
The company said the FDA's decision on its New Drug Application for RP103 (PROCYSBI) for the potential treatment of nephropathic cystinosis would be delayed by three months.
Food and Drug Administration ("FDA") seeking approval to market its investigational drug candidate, Cysteamine Bitartrate Delayed- release Capsules (RP103), for the potential treatment of nephropathic cystinosis.
Raptor currently has product candidates in clinical development to treat nephropathic cystinosis, non-alcoholic steatohepatitis ("NASH"), Huntington's Disease ("HD"), and aldehyde dehydrogenase ("ALDH2") deficiency.
According to the WHO life quality questionnaire, QOL is negatively affected in diabetic nephropathic patients with microalbuminuria (32).
Kaiser-Kupfer experienced success in reducing visual loss associated with the rare metabolic disorders gyrate atrophy and nephropathic cystinosis.
Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay.
Benefits of Intensive Insulin Therapy Formerly on Formerly on Nephropathic Intensive Therapy Conventional Therapy Outcome (n = 687) (n = 688) Hypertension 29.